Blocking PD-L1 and CD47 on CTCs increases the production of PD1+ B-cells while blocking CD47 on CTCs promotes phagocytosis by macrophages and stimulation of tumour-specific cytotoxic T cells. Here, RPL17 is linked to neoplasm.